Yervoy Pregnancy Surveillance Study

Ipilimumab 12-month Intensive Pharmacovigilance Protocol

NCT02050594 ·Status: COMPLETED

A Study of LY3041658 in Adults With Hidradenitis Suppurativa

NCT04493502 ·Status: COMPLETED ·Phase: PHASE2

Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis

NCT05384249 ·Status: TERMINATED ·Phase: PHASE2

A Study of Itacitinib for the Prevention of Cytokine Release Syndrome Induced by Immune Effector Cell Therapy

NCT04071366 ·Status: COMPLETED ·Phase: PHASE2

A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

NCT04762277 ·Status: COMPLETED ·Phase: PHASE2

Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB2 in Healthy Subjects

NCT01922336 ·Status: COMPLETED ·Phase: PHASE1

Post-authorization Safety Study in North America to Monitor Pregnancy and Infant Outcomes Following Administration of Dupilumab During Planned or Unexpected Pregnancy

NCT04173442 ·Status: COMPLETED

Safety and Clinical Activity of Itolizumab in aGVHD

NCT05823675 ·Status: UNKNOWN ·Phase: PHASE1

A Study of the Safety and Tolerability of INCB050465 in Pemphigus Vulgaris

NCT03780166 ·Status: WITHDRAWN ·Phase: PHASE2

Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy

NCT01762852 ·Status: WITHDRAWN ·Phase: PHASE2

Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Malignancies

NCT05221320 ·Status: TERMINATED ·Phase: PHASE2

Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflammatory Bowel Disease

NCT03201445 ·Status: TERMINATED ·Phase: PHASE2

Ibrutinib and Rituxan for Chronic GVHD

NCT04235036 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

NCT04242498 ·Status: COMPLETED ·Phase: PHASE3

A Study of Barzolvolimab in Patients With Atopic Dermatitis

NCT06727552 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Abatacept to Treat Steroid Refractory Chronic Graft Versus Host Disease (cGVHD)

NCT01954979 ·Status: COMPLETED ·Phase: PHASE1

Hidradenitis Suppurativa Study of Izokibep

NCT05905783 ·Status: TERMINATED ·Phase: PHASE3

Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Participants With New Onset Chronic Graft Versus Host Disease (cGVHD)

NCT02959944 ·Status: COMPLETED ·Phase: PHASE3

Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids

NCT00489216 ·Status: TERMINATED ·Phase: NA

Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Psoriasis

NCT00658827 ·Status: COMPLETED

A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease

NCT07190196 ·Status: RECRUITING ·Phase: PHASE3

A Study of VAC85135, a Neoantigen Vaccine Regimen, Concurrently Administered With Ipilimumab for the Treatment of Myeloproliferative Neoplasms

NCT05444530 ·Status: COMPLETED ·Phase: PHASE1

GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease

NCT00228839 ·Status: COMPLETED ·Phase: PHASE1

Spesolimab in Pyoderma Gangrenosum

NCT06092216 ·Status: TERMINATED ·Phase: PHASE2

A Study of LY3006072 in Healthy Participants

NCT01640249 ·Status: TERMINATED ·Phase: PHASE1